As they seem to be back in our paddock, consider the bolded...

As they seem to be back in our paddock, consider the bolded text.


From the website

RA Capital Management, LLC (“RA Capital”) is a crossover fund manager dedicated to (1)evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with fewer capital concerns from inception through commercialization.​

At RA Capital’s core is its TechAtlas research division, a scientifically trained team that (3)maps out competitive landscapes in a continual effort to put data into context, identify breakthroughs, and originate conviction in new ideas. TechAtlas provides RA Capital’s investment team and portfolio companies (see Beyond Capital) with strategic intelligence, market research, and other resources. (4)The team’s understanding of industry best practices is derived from an extensive collection of case studies documenting the impact of clinical trial design, partnership structures, public market dynamics, and many other factors on valuation and business viability.

Perhaps now they think BLT is worthy of their investment/advice/guidance.
(1) Evidence based - "they may believe that compelling evidence is forthcoming"
(2) Follow-on financings for its portfolio companies If they finance BLT they are partners and can guide company as we know it needs
(3) Maps out competitive landscapes Sell the process to attract big pharma for partnerships(allready?)
(4) Practices is derived from an extensive collection of case studies documenting the impact of clinical trial design BLT has changed its methods of realeasing info which now is more suited to RC's principals

Just a few thoughts to detract from the doom and gloom of the day to day crystal ball gazing we subject ourselves too.
The next ASX anouncement on change in holding will be a defining document I believe.